Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(42%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
11
92%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

12

all time

Status Distribution
Active(8)
Completed(3)
Other(1)

Detailed Status

Recruiting5
Completed3
Not yet recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
5
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

completed325%
unknown18%
recruiting542%
not_yet_recruiting325%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT07479082Not Applicable

Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Headache Following Stent-Assisted Coiling of Unruptured Intracranial Aneurysms

Recruiting
NCT07425756Not Applicable

taVNS Combined With TENS on Motor Function in Stroke

Recruiting
NCT07173400Not Applicable

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Symptom Severity, Sleep Quality, Central Sensitization, and Kinesiophobia in Fibromyalgia

Completed
NCT07260266Not Applicable

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Opioid Consumption in Patients Undergoing Major Abdominal Surgery

Not Yet Recruiting
NCT06784583Not Applicable

A Study on Transcutaneous Vagus Nerve Stimulation in Perioperative Period of Percutaneous Coronary Intervention

Completed
NCT06287970Not Applicable

TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS

Recruiting
NCT04849507Not Applicable

BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Paired Bottle Feeding to Improve Oral Feeding

Completed
NCT07022171Not Applicable

Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation in Depression

Recruiting
NCT06953388Phase 1

Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD

Not Yet Recruiting
NCT06493071Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI

Recruiting
NCT06623591Not Applicable

Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients.

Not Yet Recruiting
NCT05950347Not Applicable

The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Anxiety in PD

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12